We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

Pfizer (PFE) closed the latest trading day at $29.42, indicating a -0.83% change from the previous session's end. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow gained 0.09%, ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

The hits just keep on coming for Bristol Myers Squibb staffers amid the company's cost-savings program.  | Bristol Myers ...

Tris Pharma, Inc. (Tris) has announced the promotion of Manesh Naidu, MBA, to chief commercial officer. Naidu previously ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Institutional Property Advisors (IPA), a division of Marcus & Millichap, has arranged $75 million in financing for the redevelopment of the former Pfizer headquarters building in Midtown Manhattan.

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo ...

Prime Minister of Greece Kyriakos Mitsotakis will be in New York the week of September 22 to participate in the 79th UN ...

Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...